- Home
- FBRX vs CRNC Comparison
FBRX vs CRNC Comparison
Compare FBRX & CRNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FBRX | CRNC |
|---|---|---|
| Founded | N/A | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 487.2M | 479.9M |
| IPO Year | 2017 | 2019 |
Fundamental Metrics
Financial Performance| Metric | FBRX | CRNC |
|---|---|---|
| Price | $21.06 | $11.42 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 4 |
| Target Price | ★ $67.00 | $10.25 |
| AVG Volume (30 Days) | 369.5K | ★ 1.0M |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 61.30 | ★ 96.95 |
| EPS | N/A | ★ N/A |
| Revenue | $36,000.00 | ★ $251,781,000.00 |
| Revenue This Year | N/A | $27.18 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.12 | $5.85 |
| 52 Week High | $35.80 | $13.74 |
Technical Indicators
Market Signals| Indicator | FBRX | CRNC |
|---|---|---|
| Relative Strength Index (RSI) | 58.78 | 56.53 |
| Support Level | $16.58 | $10.71 |
| Resistance Level | $22.84 | $11.49 |
| Average True Range (ATR) | 1.40 | 0.74 |
| MACD | 0.77 | -0.01 |
| Stochastic Oscillator | 81.45 | 94.23 |
Price Performance
Historical ComparisonAbout FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.
About CRNC Cerence Inc.
Cerence Inc is a United States-based software company. It is involved in developing mobility-based solutions for drivers and their cars. The customers include all automobile original equipment manufacturers, or OEMs, or their tier 1 suppliers. The company's revenue is generated by selling software licenses and cloud-connected services. Geographically, it derives a majority of its revenue from the United States and also has a presence in Other Americas; Germany; Other Europe, the Middle East, Africa; Japan, and Other Asia-Pacific.